89
85
Growth Score
-1 pts
Heat Score
30 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
196078
Translational Drug Development is a contract research organization that focuses on oncology therapies.
Acquired by 
Research Corporation Technologies
Jennifer S. Keppler: Vice President & Translational MedicinePast Role: ImaginAb, Chief Operating Officer- STEPHEN GATELY: CEO
About the Company
Translational Drug Development is a biotechnology company intended to develop translational oncology support to treat cancer. Their platform conducts clinical programs that predict unique contexts of sensitivity for new medicines which then provide accelerated patient benefits in clinical testing, enabling oncology researchers to examine and
prepare proper cancer drugs.
